Upload
alexandra-wells
View
215
Download
3
Embed Size (px)
Citation preview
Deferral of MSMby Andrew I. Dayton, M.D., Ph. D.
•The HIV epidemic in the U.S.A. is generally recognized to have started just after 1977.
•Currently MSM are deferred for MSM behavior “…even one time, since 1977…”
•In 1997 FDA presented to the BPAC an analysis of the potential effects of relaxing the MSM deferral policy to “1 year” or to “5 years.”
•Blood banking errors, poorly quantified at the time, were considered the most significant risk of changing the policy.
Deferral of MSMby Andrew I. Dayton, M.D., Ph. D.
•In November of 1998, FDA hosted a workshop on Donor Suitability.
•The highlights of this workshop were presented to the BPAC in December of 1998.
Widespread adoption of NAT for HCV and HIV, providing, amongst other benefits, redundancy.
Better understanding of blood bank error rates.
Protection of the Blood Supply
INFECTIONPOTENTIAL DONORS
BLOOD SUPPLY
TestsQuestionnaire
Undetectable Strains
Blood Bank Error
Test Failure
Window Period
Ineffective Risk Identification
Test Seeking Behavior
Peer Pressure
Misunderstanding of Questions
Self Deferral (Education)
Protection of the Blood Supply
POTENTIAL DONORS
BLOOD SUPPLY
Tests
Undetectable Strains
Blood Bank Error
Test Failure
Window Period
Prevalence
Incidence
Quantitation of Errors I:How many infectious units will “get through?”
Total Errors = P x (U + E + F ) + I x (WP/365)} x Population
Errors = P x (U + E + F ) + I x (WP/365)} x Population